Human medicines European public assessment report (EPAR): GalliaPharm, Gallium (68Ga) chloride,Germanium (68Ge) chloride,...
On 30 May 2024, the Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending the granting of a marketing authorisation for the medicinal product GalliaPharm, a radionuclide generator. GalliaPharm is not intended for …